First amongst small and mid-sized enterprises to have a vertical integration in three critical functions in the Pharma value chain.
– BA/BE Studies.
All facilities are FDA/EU/Health Canada compliant
•API division - manufacture of niche API's, intermediates in cGMP & FDA Approved facility.
• Formulation Division – development and manufacture of advanced drug delivery systems with emphasis on sustained release under cGMP conditions.
• BA/BE division -which undertakes full service contract research activities in the areas of Bio- Availability and Bio-
Equivalence in an FDA approved facility.